Lecanemab Gains FDA Approval for Early Alzheimer Disease

被引：57

作者：

Larkin, Howard D. D.

机构：

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2023年 / 329卷 / 05期

关键词：

D O I：

10.1001/jama.2022.24490

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：363 / 363

页数：1

共 50 条

[11] GE salmon gains FDA approval
Cima, Greg
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2016, 248 (01): : 25 - 25
[12] Leptin therapy gains FDA approval
Gunjan Sinha
Nature Biotechnology, 2014, 32 : 300 - 301
[13] Integrase inhibitor gains FDA approval
Traynor, Kate
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (22) : 2310 - 2310
[14] Leptin therapy gains FDA approval
Sinha, Gunjan
NATURE BIOTECHNOLOGY, 2014, 32 (04) : 300 - 302
[15] Sugar substitute gains FDA approval
不详
FOOD AUSTRALIA, 1998, 50 (06): : 262 - 262
[16] Alzheimer?s disease: FDA approves lecanemab amid cost and safety concerns
Mahase, Elisabeth
BMJ-BRITISH MEDICAL JOURNAL, 2023, 380 : p73
[17] Implications of the Approval of Lecanemab for Alzheimer Disease Patient Care Incremental Step or Paradigm Shift?
Knopman, David S.
Hershey, Linda
NEUROLOGY, 2023, 101 (14) : 610 - 620
[18] Catheter gains US FDA approval for treating peripheral vascular disease
不详
EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2010, 8 (08) : 1054 - 1054
[19] Lecanemab for Alzheimer's disease
Walsh, Sebastian
Merrick, Richard
Richard, Edo
Nurock, Shirley
Brayne, Carol
BMJ-BRITISH MEDICAL JOURNAL, 2022, 379
[20] Lecanemab for Alzheimer's disease
Walsh, Sebastian
Merrick, Richard
Richard, Edo
Nurock, Shirley
Brayne, Carol
BMJ-BRITISH MEDICAL JOURNAL, 2022, 379